Misclassification of colorectal cancer stage and area variation in survival

International Journal of Cancer

Volumn 122, Issue 2, 2008, Pages 398-402

  Yu, Xue Q ^a   O'Connell, Dianne L ^a   Gibberd, Robert W ^b   Abrahamowicz, Michal ^c   Armstrong, Bruce K ^d  

^a CANCER RESEARCH DIVISION   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Misclassification; Population based cancer registry; Regional variation; Stage specific survival; Staging error

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DISEASE SIMULATION; FEMALE; HEALTH SURVEY; HUMAN; MALE; PATIENT CODING; PRIORITY JOURNAL; PROBABILITY; RECTUM CANCER; SURGEON; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS; PROBABILITY; REGISTRIES; SEER PROGRAM; SURVIVAL ANALYSIS;

EID: 36849013231     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23043     Document Type: Article

References (34)

1. Young JL, Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA, eds. SEER summary staging manual - 2000: codes and coding instructions. Bethesda, MD: National Cancer Institute, 2001.
2. Cooper GS, Yuan Z, Stange KC, Amini SB, Dennis LK, Rimm AA. The utility of medicare claims data for measuring cancer stage. Med Care 1999;37:706-11.
3. Liu WL, Kasl S, Flannery JT, Lindo A, Dubrow R. The accuracy of prostate cancer staging in a population-based tumor registry and its impact on the black-white stage difference (Connecticut, United States). Cancer Causes Control 1995;6:425-30.
4. Schouten LJ, Langendijk JA, Jager JJ, van den Brandt PA. Validity of the stage of lung cancer in records of the Maastricht cancer registry, The Netherlands. Lung Cancer 1997;17:115-22.
5. Jensen AR, Overgaard J, Storm HH. Validity of breast cancer in the Danish cancer registry. A study based on clinical records from one county in Denmark. Eur J Cancer Prev 2002;11:359-64.
6. Malin JL, Kahn KL, Adams J, Kwan L, Laouri M, Ganz PA. Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst 2002;94:835-44.
7. Yu XQ, O'Connell DL, Gibberd RW, Armstrong BK. A population-based study from New South Wales, Australia 1996-2001: area variation in survival from colorectal cancer. Eur J Cancer 2005;41:2715-21.
8. Yu XQ, O'Connell DL, Gibberd RW, Smith DP, Dickman PW, Armstrong BK. Estimating regional variation in cancer survival: a tool for improving cancer care. Cancer Causes Control 2004;15:611-18.
9. Ciccolallo L, Capocaccia R, Coleman MP, Berrino F, Coebergh JW, Damhuis RA, Faivre J, Martinez-Garcia C, Møller H, Ponz de Leon, Launoy G, Raverdy N, et al. Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut 2005;54:268-73.
10. Gatta G, Capocaccia R, Sant M, Bell CM, Coebergh JW, Damhuis RA, Faivre J, Martinez-Garcia C, Pawlega J, Ponz de Leon, Pottier D, Raverdy N, et al. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 2000;47: 533-8.
11. Brenner H, Gefeller O. An alternative approach to monitoring cancer patient survival. Cancer 1996;78:2004-10.
12. Brenner H, Gefeller O. Deriving more up-to-date estimates of long-term patient survival. J Clin Epidemiol 1997;50:211-16.
13. Armstrong K, O'Connell DL, Leong D, Spigelman AD, Armstrong BK. The New South Wales colorectal cancer care survey, Part 1: surgical management. Sydney: The Cancer Council New South Wales, 2004.
14. Vality Technology Incorporated. The INTEGRITY data re-engineering environment user guide (Version 3.6). Boston, USA: Vality Technology Incorporated, 2000.
15. Brameld KJ, Thomas MA, Holman CD, Bass AJ, Rouse IL. Validation of linked administrative data on end-stage renal failure: application of record linkage to a 'clinical base population'. Aust N Z J Public Health 1999;23:464-7.
16. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
17. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. National Cancer Inst Monogr 1961;6:101-21.
18. Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med 2004;23:51-64.
19. Coory M, Gibberd R. New measures for reporting the magnitude of small-area variation in rates. Stat Med 1998;17:2625-34.
20. Greenland S, Robins JM. Empirical-Bayes adjustments for multiple comparisons are sometimes useful. Epidemiology 1991;2:244-51.
21. Gibberd R, Pathmeswaran A, Burtenshaw K. Using clinical indicators to identify areas for quality improvement. J Qual Clin Pract 2000;20: 136-44.
22. Howley PP, Gibberd R. Using hierarchical models to analyse clinical indicators: a comparison of the γ-Poisson and β-binomial models. Int J Qual Health Care 2003;15:319-29.
23. Morton AP, Dobson AJ. Assessing agreement. Med J Aust 1989; 150:384-7.
24. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420-8.
25. Phillips KA, Milne RL, Buys S, Friedlander ML, Ward JH, McCredie MR, Giles GG, Hopper JL. Agreement between self-reported breast cancer treatment and medical records in a population-based breast cancer family registry. J Clin Oncol 2005;23:4679-86.
26. Gulliford MC, Bell J, Bourne HM, Petruckevitch A. The reliability of cancer registry records. Br J Cancer 1993;67:819-21.
27. Jestin P, Pahlman L, Glimelius B, Gunnarsson U. Cancer staging and survival in colon cancer is dependent on the quality of the pathologists' specimen examination. Eur J Cancer 2005;41:2071-8.
28. Sant M, Allemani C, Berrino F, Coleman MP, Aareleid T, Chaplain G, Coebergh JW, Colonna M, Crosignani P, Danzon A, Federico M, Gafa L, et al. Breast carcinoma survival in Europe and the United States. Cancer 2004;100:715-22.
29. Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW, Coleman MP, Grosclaude P, Martinez C, Bell J, Youngson J, Berrino F. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 2003;106:416-22.
30. Riley GF, Potosky AL, Klabunde CN, Warren JL, Ballard-Barbash R. Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison. JAMA 1999; 281:720-6.
31. Johnson PM, Porter GA, Ricciardi R, Baxter NN. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol 2006;24:3570-5.
32. Jong KE, Smith DP, Yu XQ, O'Connell DL, Goldstein D, Armstrong BK. Remoteness of residence and survival from cancer in New South Wales. Med J Aust 2004;180:618-22.
33. Yu XQ, O'Connell DL, Gibberd RW, Coates AS, Armstrong BK. Trends in survival and excess risk of death after diagnosis of cancer in 1980-1996 in New South Wales, Australia. Int J Cancer 2006;119: 894-900.
34. Condon JR, Barnes T, Armstrong BK, Selva-Nayagam S, Elwood JM. Stage at diagnosis and cancer survival for indigenous Australians in the northern territory. Med J Aust 2005;182:277-80.